Overview
- Editors:
-
-
Pamela J. Russell
-
Oncology Research Centre, Prince of Wales Hospital, Randwick, Australia
-
Paul Jackson
-
Oncology Research Centre, Prince of Wales Hospital, Randwick, Australia
-
Elizabeth A. Kingsley
-
Oncology Research Centre, Prince of Wales Hospital, Randwick, Australia
Access this book
Other ways to access
Table of contents (22 protocols)
-
-
-
- Pamela J. Russell, Elizabeth A. Kingsley
Pages 21-39
-
-
- David L. Hudson, John R. W. Masters
Pages 59-67
-
-
- George Sgouros, Wei-Hong Yang, Richard Enmon
Pages 79-88
-
- Pamela J. Russell, Dale J. Voeks
Pages 89-112
-
- Susan Kasper, William Tu, Richard L. Roberts, Scott B. Shappell
Pages 113-147
-
-
- Elin Mortensen, Julie M. Brown
Pages 163-179
-
-
- R. A. Gardiner, Michelle Burger, Judith A. Clements, Martin F. Lavin
Pages 199-217
-
- Susan J. Clark, Douglas S. Millar, Peter Molloy
Pages 219-240
-
- Tracey J. Harvey, Ying Dong, Loan Bui, Russell Jarrott, Terry Walsh, Judith A. Clements
Pages 241-254
-
- Peter E. Clark, Ryan A. Irvine, Gerhard A. Coetzee
Pages 255-266
-
- Zoran Culig, Alfred Hobisch, Martin Erdel, Georg Bartsch, Helmut Klocker
Pages 267-275
-
- Soren Naaby-Hansen, Kohji Nagano, Piers Gaffney, John R. W. Masters, Rainer Cramer
Pages 277-297
-
- Colleen C. Nelson, Douglas Hoffart, Martin E. Gleave, Paul S. Rennie
Pages 299-320
-
- Fujiko Watt, Peter Molloy
Pages 321-331
About this book
Prostate cancer is the second leading cancer in men in Western society. A major concern, and an area of intensive research, involves understanding why certain prostate cancers remain localized or indolent, whereas others become aggressive and metastasize. The differences between these cancer types have profound implications for patients and physicians. Indolent d- ease, which grows very slowly, generally does not cause any problems to the patient, whereas aggressive disease requires immediate treatment, the earlier the better. At present, there are no markers that discriminate between these two entities, thus causing a dilemma for the management of patients who have recently been diagnosed. The aim of Prostate Cancer Methods and Protocols is to explore cutting-edge molecular methods that may have the potential to reveal markers of disease for use in more accurate diagnoses of prostate c- cer and, consequently, to lead to new treatment strategies. This book provides a comprehensive collection of both in vitro and in vivo step-by-step protocols currently used by leaders in prostate cancer research, advice on approaches that can be used in the study of prostate cancer, as well as reviews covering areas less amenable to laboratory research, such as environmental factors in prostate cancer, to provide the reader with an overview of the prostate cancer research field as it currently stands.
Reviews
"I know of no other book similar to this important compendium of methods for the study of prostate cancer. It is organized and edited skillfully and will be useful for any scientist-physician interested in the study of prostate cancer." -Doody's Health Sciences Book Review Journal
"...recommended for purchase by large health science or cancer research libraries. Or any library, which servies researchers and scientists, working on prostate cancer." - E-Streams
